| NCT ID | NCT03925389 |
| Status | Recruiting |
| Phase | — |
| Sponsor | FRANK DECLAU |
| Condition | Rhinoplasty |
| Study Type | OBSERVATIONAL |
| Enrollment | 750 participants |
| Start Date | 2019-05-07 |
| Primary Completion | 2025-12-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 750 participants in total. It began in 2019-05-07 with a primary completion date of 2025-12-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A prospective observational cohort study that measures pre- and postoperative outcome of septorhinoplasty by means of patient-related outcome measures (PROMS: NOSE, FACE-Q, Utrecht Questionnaire, SCHNOS and BDDQ-AS) as well as with functional tests (NAR, AR, PNIF).
Eligibility Criteria
Inclusion Criteria: * at least 18 years old * Patients eligible for external septorhinoplasty: patients seen in consultation because of nasal obstruction were evaluated. Patients who had symptoms of nasal obstruction for at least 1 year that were the result of an identifiable anatomical cause such as septal deviation, turbinate hypertrophy, internal valve collapse, or external valve collapse were included in the study. Exclusion Criteria: * \< 18 years * mental or physical incapacity to answer the questionnaires * nasal fracture or surgery in the past year * nasal cocaine use in the past year
Contact & Investigator
Frank Declau, MD, PhD
PRINCIPAL INVESTIGATOR
Universiteit Antwerpen
Frequently Asked Questions
Who can join the NCT03925389 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Rhinoplasty. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03925389 currently recruiting?
Yes, NCT03925389 is actively recruiting participants. Contact the research team at nko@telenet.be for enrollment information.
Where is the NCT03925389 trial being conducted?
This trial is being conducted at Antwerp, Belgium.
Who is sponsoring the NCT03925389 clinical trial?
NCT03925389 is sponsored by FRANK DECLAU. The principal investigator is Frank Declau, MD, PhD at Universiteit Antwerpen. The trial plans to enroll 750 participants.